Clinical Trial 55269

Berlin, NJ 08009


Summary:

A 6-Month Phase 3, Multicenter, Prospective, Randomized, Double-Blind, Vehicle-Controlled Study, to Evaluate the Efficacy and Safety of Topically Applied Clascoterone (Cortexolone 17?-Propionate) Solution for the Treatment of Androgenetic Alopecia in Males, Followed by a 6-Month Single-Blind Treatment with Clascoterone or Vehicle BID Solution



Criteria:
  • Male
  • At least 18 years old
  • Have mild to moderate androgenetic alopecia (male pattern baldness)
    • Must be rating 3 vertex to 5
  • History of ongoing hair loss
  • Additional criteria apply


Qualified Participants May Receive:

Compensation up to $925–$1,175 for time and travel-related expenses


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.